Catalyst Wire Dossier Catalyst Wire Dossier

brigimadlin

brigimadlin · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for brigimadlin, covering 2024-07-17 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine [Phase 2]

See pricing